My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Verve Therapeutics, Inc. - Common Stock (NQ:VERV)

11.13 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Verve Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022 ↗

December 15, 2022

Via Benzinga

Why Verve Therapeutics' Stock Dropped 26.33% on Monday ↗

November 07, 2022

A trial for the company's lead therapy was put on hold.

Via The Motley Fool

Cathie Wood Adds $7M Of This Clinical-Stage Biotech, Trims Stake In CVS-Target Signify Health ↗

December 07, 2022

Cathie Wood-led ARK Investment Management bought over 330,000 shares of clinical-stage biotechnology company Verve Therapeutics Inc (NASDAQ: VERV) at an estimated valuation of over $6.9 million, based...

Via Benzinga

Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session ↗

December 05, 2022

Gainers Winc, Inc. (NYSE: WBEV) rose 88.5% to $0.3901 after dropping over 23% on Friday. Winc, last month, posted a Q3 loss of $0.33 per share.

Via Benzinga

Gold Down 1%; China Pharma Shares Spike Higher ↗

December 05, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 200 points on Monday.

Via Benzinga

Why Shares Of CRISPR-Focused Verve Therapeutics Just Took A Grim Turn ↗

October 31, 2022

The company is testing a CRISPR-based approach to high cholesterol.

Via Investor's Business Daily

VF Corp, Verve Therapeutics And Some Other Big Stocks Moving Lower On Monday ↗

December 05, 2022

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

US Stocks Start Week On Lower Note; Dow Tumbles 250 Points ↗

December 05, 2022

U.S. stocks traded lower this morning, with the Dow Jones falling around 250 points on Monday.

Via Benzinga

Verve Therapeutics Stock Skids On The FDA's Long List Of Gene-Editing Concerns ↗

December 05, 2022

The company has a long list of issues to address to satisfy the FDA's worries.

Via Investor's Business Daily

Looking Into Verve Therapeutics's Recent Short Interest ↗

November 23, 2022

Verve Therapeutics's (NASDAQ:VERV) short percent of float has fallen 10.98% since its last report. The company recently reported that it has 10.05 million shares sold short, which is 29.91% of all...

Via Benzinga

Dow Surges 400 Points; Crude Oil Down 1% ↗

November 07, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 400 points on Monday.

Via Benzinga

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗

November 08, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 07, 2022

Gainers

Via Benzinga

Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session ↗

November 07, 2022

Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.

Via Benzinga

Looking Into Verve Therapeutics's Recent Short Interest ↗

November 07, 2022

Verve Therapeutics's (NASDAQ:VERV) short percent of float has fallen 11.53% since its last report. The company recently reported that it has 10.73 million shares sold short, which is 33.6% of all...

Via Benzinga

Dow Jumps Over 200 Points; Verve Therapeutics Shares Plummet ↗

November 07, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Monday.

Via Benzinga

Dow Up Triple Digits Ahead Of Busy Week ↗

November 07, 2022

The Dow Jones Industrial Average is up 212 points midday, continuing Friday's flourish, while the Nasdaq Composite and S&P 500 Index sit more hesitantly in the black.

Via Talk Markets

IAA Stock Moves as Ritchie Bros Acquires Company in $7.3 Billion Deal ↗

November 07, 2022

IAA (IAA) stock is moving on Monday thanks to a massive acquisition $7.3 billion deal with Ritchie Bros Auctioneers (RBA).

Via InvestorPlace

Verve Therapeutics Shares Tumble After FDA Hold On Trial For Elevated Cholesterol Level Candidate ↗

November 07, 2022

Via Benzinga

Why Is Verve Therapeutics (VERV) Stock Down 28% Today? ↗

November 07, 2022

Verve Therapeutics (VERV) stock is taking a beating on Monday following bad news from the U.S. Food and Drug Administration (FDA).

Via InvestorPlace

TreeHouse Foods, Ritchie Bros. Auctioneers, Beam Therapeutics And Some Other Big Stocks Moving Lower On Monday ↗

November 07, 2022

U.S. stocks traded mostly higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

US Stocks Mixed; Dow Rises Over 50 Points ↗

November 07, 2022

U.S. stocks traded mixed this morning, with the Dow Jones gaining over 50 points on Monday.

Via Benzinga

Verve Crashes After FDA Halts Plan To Test Gene Editor In People ↗

November 07, 2022

Verve Therapeutics hopes to use a next-generation form of CRISPR called base editing.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 07, 2022

Gainers Cidara Therapeutics (NASDAQ:CDTX) shares rose 14.6% to $0.64 during Monday's pre-market session. The market value of their outstanding shares is at $44.9 million. The company's, Q3 earnings...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 07, 2022

Good morning, investor! We're diving into the biggest pre-market stock movers for Monday as we get ready for another week of trading!

Via InvestorPlace

CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures? ↗

October 20, 2022

Despite enthusiasm in some camps, the risk of potential cures clouds market projections.

Via Investor's Business Daily

A Look Into Healthcare Sector Value Stocks ↗

October 10, 2022

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base...

Via Benzinga

Verve's Stock Price Could Continue To Rise Through Clinical Progress - Despite Worries About "DeeperPocketed" Competition ↗

October 06, 2022

Via Benzinga

Cathie Wood Just Bought the TSLA Stock Dip. Should You? ↗

October 04, 2022

Cathie Wood is doubling down on TSLA stock. Here's why investors may want to follow her lead before markets shift in 2023.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022 ↗

October 06, 2022

Upgrades

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.